Status:
COMPLETED
Pharmacy-based Pre-exposure Prophylaxis
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed research will develop a culturally appropriate pharmacy pre-exposure prophylaxis (PrEP) delivery model for black men who have sex with men (BMSM) who live in high poverty, racial minority...
Detailed Description
Black men who have sex with men (BMSM) bear the highest burden of HIV in the US. PrEP is the single most effective HIV prevention strategy yet under-utilized among BMSM. When taken every day PrEP can ...
Eligibility Criteria
Inclusion
- Consent to participate in the online screener
- Can speak and read English without any help
- Test negative for HIV
- Agree to receive medication from the pharmacy
Exclusion
- none
Key Trial Info
Start Date :
May 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 11 2024
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04393935
Start Date
May 19 2022
End Date
May 11 2024
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322